Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Image contrast agents activated by prostate specific antigen (PSA).

Graham B Jones1, Longfei Xie, Ahmed El-Shafey

  • 1Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA. gr.jones@neu.edu

Bioorganic & Medicinal Chemistry Letters
|May 20, 2004
PubMed
Summary

Synthesized novel image contrast agents activate with specific enzymes, releasing detectable fluorophores. This enzymatic activation offers a new method for targeted imaging applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and racial predictors of adverse pathology at radical prostatectomy: implications for undertreatment among patients receiving radiation and hormonal therapy.

The Canadian journal of urology·2026
Same author

Postoperative Pelvic Lymph Node Radiation Therapy in Lymph Node-Positive Prostate Cancer and Mortality Risk.

European urology focus·2026
Same author

Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis.

Cancer·2026
Same author

Surveillance Versus Treatment for Favorable Intermediate-Risk Prostate Cancer and Mortality-Risk.

The Prostate·2026
Same author

Cribriform-Positive and -Negative Prostate Cancer.

JAMA oncology·2026
Same author

FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide.

European urology·2026

Area of Science:

  • Bioconjugation Chemistry
  • Enzyme-Activated Imaging Agents

Background:

  • Development of targeted imaging agents is crucial for early disease detection.
  • Enzymatic activation offers a strategy for site-specific contrast release.

Purpose of the Study:

  • To synthesize and characterize a novel family of enzyme-activatable image contrast agent conjugates.
  • To demonstrate the enzymatic cleavage and subsequent release of a fluorophore.

Main Methods:

  • Synthesis of a three-component conjugate system.
  • Incubation of conjugates with prostate specific antigen (PSA) and alpha-chymotrypsin.
  • Analysis of released fluorophore via cleavage assays.

Main Results:

  • Successful synthesis of image contrast agent conjugates.

Related Experiment Videos

  • Demonstrated enzymatic activation by both prostate specific antigen and alpha-chymotrypsin.
  • Confirmed release of free fluorophore upon enzymatic cleavage.

    • Conclusions:

    • A new class of enzyme-activatable contrast agents has been developed.
    • These agents can be selectively activated by specific enzymes, releasing a detectable signal.
    • Potential applications in targeted molecular imaging and diagnostics.